Healthcare

Coalesce Capital Acquires Leading Healthcare IT and Business Solutions Provider DAS Health

NEW YORK and TAMPA, Fla., May 27, 2025 /PRNewswire/ -- Coalesce Capital ("Coalesce"), a private equity firm focused on investing…

7 months ago

Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an…

7 months ago

Wilson Sonsini Expands Health Privacy and Regulatory Capabilities With the Addition of Jodi Daniel

Former HHS Leader and Digital Health Pioneer Brings Unparalleled Experience to Strengthen the Firm’s Growing PracticeWASHINGTON--(BUSINESS WIRE)--Wilson Sonsini Goodrich &…

7 months ago

Forte Medical Revolutionises Women’s Routine Health with Peezy Midstream

Innovative Device Brings UTI and Antenatal Screening into the 21st Century with Unmatched Dignity, Hygiene and AccuracyLONDON, May 27, 2025…

7 months ago

Leo International leaps from Lion City to Frankfurt with AI precision health listing

SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- In a landmark announcement that bridges Asia and Europe, Leo International Group has…

7 months ago

Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting

Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with improved pathologic response.ROCHESTER, N.Y., May 27,…

7 months ago

Masimo to Present in the Jefferies Global Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday,…

7 months ago

Strongline returns to market, signs deal with QLog to ensure leading staff duress offering is available to health systems around the country

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- Commure announced today a strategic partnership and licensing agreement with QLog, a…

7 months ago

IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025

Presentation at ESMO will follow oral 2025 ASCO Annual Meeting presentation highlighting unprecedented survival data from Phase 2 OVATION 2…

7 months ago